Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.

Gilioli D, Fusco S, Tavella T, Volpari T, Santoro A, Schönlein M, Giannetti K, Carsana E, Gualandi N, Noberini R, Brombin C, Russo S, Feola S, Giannoula Y, Branca RMM, Lehtiö J, Sikanen TM, Haapala M, Passerini L, Andrisani A, Farina G, Zangari A, Conti A, Della Volpe L, Barcella M, Beretta S, Aletti FM, Carrabba MG, Gregori S, Bonini C, Merelli I, Ciceri F, Cerullo V, Bonaldi T, Vago L, Schmitt CA, Di Micco R

Open source

DOI
10.1038/s41467-026-76853-1
Published
2026 Sep 4
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-76853-1,
  title = {Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.},
  author = {Gilioli D and Fusco S and Tavella T and Volpari T and Santoro A and Schönlein M and Giannetti K and Carsana E and Gualandi N and Noberini R and Brombin C and Russo S and Feola S and Giannoula Y and Branca RMM and Lehtiö J and Sikanen TM and Haapala M and Passerini L and Andrisani A and Farina G and Zangari A and Conti A and Della Volpe L and Barcella M and Beretta S and Aletti FM and Carrabba MG and Gregori S and Bonini C and Merelli I and Ciceri F and Cerullo V and Bonaldi T and Vago L and Schmitt CA and Di Micco R},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-76853-1},
  url = {https://doi.org/10.1038/s41467-026-76853-1}
}

RIS

TY  - JOUR
TI  - Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.
AU  - Gilioli D
AU  - Fusco S
AU  - Tavella T
AU  - Volpari T
AU  - Santoro A
AU  - Schönlein M
AU  - Giannetti K
AU  - Carsana E
AU  - Gualandi N
AU  - Noberini R
AU  - Brombin C
AU  - Russo S
AU  - Feola S
AU  - Giannoula Y
AU  - Branca RMM
AU  - Lehtiö J
AU  - Sikanen TM
AU  - Haapala M
AU  - Passerini L
AU  - Andrisani A
AU  - Farina G
AU  - Zangari A
AU  - Conti A
AU  - Della Volpe L
AU  - Barcella M
AU  - Beretta S
AU  - Aletti FM
AU  - Carrabba MG
AU  - Gregori S
AU  - Bonini C
AU  - Merelli I
AU  - Ciceri F
AU  - Cerullo V
AU  - Bonaldi T
AU  - Vago L
AU  - Schmitt CA
AU  - Di Micco R
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-76853-1
UR  - https://doi.org/10.1038/s41467-026-76853-1
ER  - 

APA

D, G., S, F., T, T., T, V., A, S., M, S., K, G., E, C., N, G., R, N., C, B., S, R., S, F., Y, G., RMM, B., J, L., TM, S., M, H., L, P., A, A., G, F., A, Z., A, C., L, D. V., M, B., S, B., FM, A., MG, C., S, G., C, B., I, M., F, C., V, C., T, B., L, V., CA, S., & R, D. M. (2026). Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.. Nature communications. https://doi.org/10.1038/s41467-026-76853-1

Source records